ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $28,000 | +7.7% | 18,930 | +4.6% | 0.00% | – |
| Q4 2016 | $26,000 | +271.4% | 18,096 | +365.2% | 0.00% | – |
| Q3 2016 | $7,000 | +40.0% | 3,890 | +37.0% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 2,840 | +35.2% | 0.00% | – |
| Q1 2016 | $4,000 | -97.7% | 2,100 | -97.7% | 0.00% | – |
| Q4 2015 | $172,000 | +537.0% | 90,777 | +553.7% | 0.00% | – |
| Q3 2015 | $27,000 | -22.9% | 13,887 | +82.7% | 0.00% | – |
| Q2 2015 | $35,000 | -53.3% | 7,600 | -55.6% | 0.00% | – |
| Q1 2015 | $75,000 | +1.4% | 17,100 | -20.2% | 0.00% | – |
| Q4 2014 | $74,000 | +428.6% | 21,439 | +556.0% | 0.00% | – |
| Q3 2014 | $14,000 | -57.6% | 3,268 | -41.2% | 0.00% | – |
| Q2 2014 | $33,000 | -2.9% | 5,558 | +3.2% | 0.00% | – |
| Q1 2014 | $34,000 | -86.6% | 5,386 | -87.6% | 0.00% | – |
| Q4 2013 | $254,000 | -62.0% | 43,428 | -65.8% | 0.00% | – |
| Q3 2013 | $669,000 | +562.4% | 126,915 | +867.9% | 0.00% | – |
| Q2 2013 | $101,000 | – | 13,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
| Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
| Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
| TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
| ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
| Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
| Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
| Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
| A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |